Homepage
No report run on this ticker yet
Only preliminary foundational data below
Sign in to run a fresh report
Free · results in ~10 min
For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Bristol-Myers Squibb Company Ce (CELG.RI) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
United States
Price
$0.08
Market Cap
$0
Employees
0
Beta
—
Avg Volume
16,388
Last Dividend
$0.04
No business description available.
Runs with full report
Earnings Schedule
Checked daily · calendar updated Jul 29 No upcoming print on the calendar yet — companies typically confirm a few weeks ahead. Last print was Jan 29, 2026.
| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jan 29, 2026 | $6.45 | $6.57 +1.9% | — | — |
| Sep 14, 2025 | $0.03 | $-0.02 -166.7% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Price Overview
Last updated: Jul 29, 2026 3:25am (just now)
Current data · timestamped when a report runs
$0.08
Change · Jul 29
-0.04 (-31.10%)
Day Range
$0.08 – $0.12
52-Week Range
$0.02 – $0.27
50-Day MA
$0.11
200-Day MA
$0.09
Volume
28,518.00
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
TD Twelve Data statement
HEX SEC filing
P/E Ratio (Price per dollar of earnings)
HEXStock Price / EPS (Diluted)
0.11
Stock Price: $0.08
EPS (Diluted): 0.71
EPS (Diluted): 0.71
P/B Ratio (Price vs net asset value)
TDStock Price / Book Value Per Share
0.95
Stock Price: $0.08
Total Equity: $1.76B
Shares: 20,429,047,996
Total Equity: $1.76B
Shares: 20,429,047,996
EV/EBITDA (Total value vs operating profit)
HEXEnterprise Value / EBITDA
—
Market Cap: $0.00
Total Debt: $1.83B
Cash: $335.59M
EBITDA: $28.74B
Total Debt: $1.83B
Cash: $335.59M
EBITDA: $28.74B
Enterprise Value (Takeover price (cap + debt - cash))
TDMarket Cap + Total Debt - Cash
—
Market Cap: $0.00
Total Debt: $1.83B
Cash: $335.59M
Total Debt: $1.83B
Cash: $335.59M
Gross Margin (Revenue left after direct costs)
HEXGross Profit / Revenue
10.2%
Gross Profit: $26.13B
Revenue: $255.11B
Revenue: $255.11B
Operating Margin (Revenue left after all operations)
HEXOperating Income / Revenue
7.2%
Operating Income: $18.35B
Revenue: $255.11B
Revenue: $255.11B
Net Margin (Revenue left as actual profit)
HEXNet Income / Revenue
5.7%
Net Income: $14.50B
Revenue: $255.11B
Revenue: $255.11B
ROE (Profit from shareholder equity)
HEXNet Income / Total Equity
825.4%
Net Income: $14.50B
Total Equity: $1.76B
Total Equity: $1.76B
ROIC (Profit from all invested capital)
HEXNOPAT / Invested Capital
485.4%
Operating Income: $18.35B
Tax Rate: 13.9%
Equity: $1.76B
Total Debt: $1.83B
Cash: $335.59M
Tax Rate: 13.9%
Equity: $1.76B
Total Debt: $1.83B
Cash: $335.59M
Current Ratio (Can it pay short-term bills)
TDCurrent Assets / Current Liabilities
1.64
Current Assets: $2.01B
Current Liabilities: $1.22B
Current Liabilities: $1.22B
Debt/Equity (Leverage — debt vs equity)
TDTotal Debt / Total Equity
1.04
Short-Term Debt: $318.57M
Long-Term Debt: $1.51B
Total Debt: $1.83B
Total Equity: $1.76B
Long-Term Debt: $1.51B
Total Debt: $1.83B
Total Equity: $1.76B
Rev/Share (Top-line per share)
HEXRevenue / Shares Outstanding
$12.49
Revenue: $255.11B
Shares: 20,429,047,996
Shares: 20,429,047,996
Book Value/Share (Net assets per share)
TD(Total Assets - Total Liabilities) / Shares
$0.09
Total Equity: $1.76B
Shares: 20,429,047,996
Shares: 20,429,047,996
FCF/Share (Real cash generated per share)
HEX(Operating Cash Flow + CapEx) / Shares
$0.01
Operating CF: $327.69M
CapEx: -$85.82M
Shares: 20,429,047,996
CapEx: -$85.82M
Shares: 20,429,047,996
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TDLast Annual Dividend / Stock Price
49.2%
Last Dividend: $0.04
Stock Price: $0.08
Stock Price: $0.08
Payout Ratio (Earnings paid out as dividends)
HEXDividends Paid / Net Income
0.6%
Dividends Paid: -$85.34M
Net Income: $14.50B
Net Income: $14.50B
Income Statement (Annual)
Last updated: Jul 29, 2026 1:02am (2h ago)| Metric | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | $280.6B | $239.3B | $174.5B | $255.1B |
| Cost of Revenue | $264.6B | $236.6B | $174.5B | $229.0B |
| Gross Profit | $15.9B | $2.7B | -$28.2M | $26.1B |
| Operating Expenses | $7.0B | $7.1B | $7.1B | $7.8B |
| Operating Income | $8.9B | -$4.3B | -$7.1B | $18.3B |
| Net Income | $7.7B | -$1.2B | -$6.2B | $14.5B |
| EBITDA | $18.3B | $5.4B | $3.0B | $28.7B |
| EPS | $0.38 | $-0.06 | $-0.30 | $0.71 |
| EPS (Diluted) | $0.38 | $-0.06 | $-0.30 | $0.71 |
Balance Sheet (Annual)
Last updated: Jul 29, 2026 3:25am (just now)| Metric | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Cash & Equivalents | $69.8M | $90.7M | $264.4M | $335.6M |
| Total Current Assets | $1.4B | $1.3B | $1.3B | $2.0B |
| Total Assets | $5.4B | $5.3B | $5.2B | $5.7B |
| Current Liabilities | $1.2B | $1.2B | $1.1B | $1.2B |
| Long-Term Debt | $1.3B | $1.3B | $1.5B | $1.5B |
| Total Liabilities | $2.5B | $2.6B | $2.6B | $2.7B |
| Total Equity | $1.8B | $1.6B | $1.4B | $1.8B |
| Retained Earnings | $1.1B | $966.2M | $734.7M | $1.1B |
Cash Flow (Annual)
Last updated: Jul 29, 2026 3:25am (just now)| Metric | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | $558.7M | $341.8M | $251.9M | $327.7M |
| Capital Expenditure | -$180.5M | -$160.1M | -$98.9M | -$85.8M |
| Free Cash Flow | $351.3M | $43.4M | $223.5M | $247.3M |
| Acquisitions (net) | -$10.0M | -$5.7M | -$15.8M | $-507,733 |
| Net Debt Issued / (Repaid) | -$33.3M | $60.5M | $83.2M | -$42.9M |
| Dividends Paid | -$237.7M | -$54.9M | -$61.0M | -$85.3M |
| Stock Buybacks | — | — | — | — |
| Net Change in Cash | $83.6M | $20.9M | $173.7M | $71.2M |
Growth Trends (YoY %)
Last updated: Jul 29, 2026 1:02am (2h ago)| Metric | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue Growth | -14.7% | -27.1% | +46.2% |
| Gross Profit Growth | -82.8% | -101.0% | +92,613.7% |
| Operating Income Growth | -148.4% | -64.6% | +357.6% |
| Net Income Growth | -115.2% | -424.0% | +335.8% |
| EBITDA Growth | -70.5% | -44.8% | +865.2% |
Dividend History (Last 20)
Last updated: Jul 29, 2026 3:25am (just now)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2022-10-04 | $0.04 | — | — | — |
| 2022-02-22 | $0.14 | — | — | — |
| 2021-09-07 | $0.08 | — | — | — |
| 2021-02-23 | $0.06 | — | — | — |
| 2021-02-22 | $0.06 | — | — | — |
| 2020-02-26 | $0.10 | — | — | — |
| 2019-02-26 | $0.09 | — | — | — |
| 2018-09-04 | $0.10 | — | — | — |
| 2018-02-26 | $0.29 | — | — | — |
| 2017-02-27 | $0.23 | — | — | — |
| 2016-02-18 | $0.22 | — | — | — |
| 2015-02-23 | $0.07 | — | — | — |
| 2014-03-03 | $0.10 | — | — | — |
| 2013-03-01 | $0.08 | — | — | — |
| 2012-02-27 | $0.04 | — | — | — |
| 2011-09-14 | $0.08 | — | — | — |
| 2011-04-18 | $0.10 | — | — | — |
| 2010-09-02 | $0.08 | — | — | — |
| 2010-04-19 | $0.10 | — | — | — |
| 2009-09-03 | $0.08 | — | — | — |
Industry Benchmarks
Compares CELG.RI against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Advanced Analysis Forensic deep-dive · three lenses
Character & Durability Scorecard
Ten long-horizon business-character traits the Quality / Value / Sentiment lenses don’t break out, scored 1–10.
No scorecard yet for CELG.RI — the ten traits are scored by the
pipeline (
ext-scorecard step) when a report is run on this ticker.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CELG.RI — it's generated by the pipeline (
market-narrative step).
Delvantic AI Findings
No AI findings yet for CELG.RI — they're generated by the
pipeline (
ai-findings step) when a report is run on this ticker.
GPT Critique
No GPT critique yet for CELG.RI — it's generated by the
pipeline (
gpt-critique step) after the AI findings above, when a
report is run on this ticker.
No community reviews yet for CELG.RI.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · twelvedata
v1.1.495 · 76c2ecbf · 2026-07-28 17:17:05